Cargando…
Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer
BACKGROUND: Paraneoplastic syndromes are most frequently associated with small cell lung carcinoma, hematologic and gynecologic malignancies while reports in head and neck cancer are rare. CASE PRESENTATION: We present the case of a 60-year old female patient who developed paraneoplastic cerebellar...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687318/ https://www.ncbi.nlm.nih.gov/pubmed/26694863 http://dx.doi.org/10.1186/s12885-015-2020-4 |
_version_ | 1782406611342458880 |
---|---|
author | Huemer, Florian Melchardt, Thomas Tränkenschuh, Wolfgang Neureiter, Daniel Moser, Gerhard Magnes, Teresa Weiss, Lukas Schlattau, Alexander Hufnagl, Clemens Ricken, Gerda Höftberger, Romana Greil, Richard Egle, Alexander |
author_facet | Huemer, Florian Melchardt, Thomas Tränkenschuh, Wolfgang Neureiter, Daniel Moser, Gerhard Magnes, Teresa Weiss, Lukas Schlattau, Alexander Hufnagl, Clemens Ricken, Gerda Höftberger, Romana Greil, Richard Egle, Alexander |
author_sort | Huemer, Florian |
collection | PubMed |
description | BACKGROUND: Paraneoplastic syndromes are most frequently associated with small cell lung carcinoma, hematologic and gynecologic malignancies while reports in head and neck cancer are rare. CASE PRESENTATION: We present the case of a 60-year old female patient who developed paraneoplastic cerebellar degeneration upon locoregional recurrence of a poorly differentiated spindle cell carcinoma of the nasal cavity and paranasal sinus. The neurological symptoms, especially ataxia, stabilized after resection of tumor recurrence and concomitant chemoradiotherapy whereas anti-Hu-antibodies remained positive. Despite the unfavorable prognosis of paraneoplastic neurological disorders associated with onconeural antibodies, the patient achieved long-standing stabilization of neurological symptoms. CONCLUSION: We report the first patient with anti-Hu antibodies and paraneoplastic cerebellar degeneration associated with a spindle cell carcinoma of the head and neck. We recommend that evaluation of neurological symptoms in patients with this tumor entity should also include paraneoplastic syndromes as differential diagnoses and suggest early extensive screening for onconeural antibodies. |
format | Online Article Text |
id | pubmed-4687318 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46873182015-12-23 Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer Huemer, Florian Melchardt, Thomas Tränkenschuh, Wolfgang Neureiter, Daniel Moser, Gerhard Magnes, Teresa Weiss, Lukas Schlattau, Alexander Hufnagl, Clemens Ricken, Gerda Höftberger, Romana Greil, Richard Egle, Alexander BMC Cancer Case Report BACKGROUND: Paraneoplastic syndromes are most frequently associated with small cell lung carcinoma, hematologic and gynecologic malignancies while reports in head and neck cancer are rare. CASE PRESENTATION: We present the case of a 60-year old female patient who developed paraneoplastic cerebellar degeneration upon locoregional recurrence of a poorly differentiated spindle cell carcinoma of the nasal cavity and paranasal sinus. The neurological symptoms, especially ataxia, stabilized after resection of tumor recurrence and concomitant chemoradiotherapy whereas anti-Hu-antibodies remained positive. Despite the unfavorable prognosis of paraneoplastic neurological disorders associated with onconeural antibodies, the patient achieved long-standing stabilization of neurological symptoms. CONCLUSION: We report the first patient with anti-Hu antibodies and paraneoplastic cerebellar degeneration associated with a spindle cell carcinoma of the head and neck. We recommend that evaluation of neurological symptoms in patients with this tumor entity should also include paraneoplastic syndromes as differential diagnoses and suggest early extensive screening for onconeural antibodies. BioMed Central 2015-12-22 /pmc/articles/PMC4687318/ /pubmed/26694863 http://dx.doi.org/10.1186/s12885-015-2020-4 Text en © Huemer et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Huemer, Florian Melchardt, Thomas Tränkenschuh, Wolfgang Neureiter, Daniel Moser, Gerhard Magnes, Teresa Weiss, Lukas Schlattau, Alexander Hufnagl, Clemens Ricken, Gerda Höftberger, Romana Greil, Richard Egle, Alexander Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer |
title | Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer |
title_full | Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer |
title_fullStr | Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer |
title_full_unstemmed | Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer |
title_short | Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer |
title_sort | anti-hu antibody associated paraneoplastic cerebellar degeneration in head and neck cancer |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687318/ https://www.ncbi.nlm.nih.gov/pubmed/26694863 http://dx.doi.org/10.1186/s12885-015-2020-4 |
work_keys_str_mv | AT huemerflorian antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT melchardtthomas antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT trankenschuhwolfgang antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT neureiterdaniel antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT mosergerhard antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT magnesteresa antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT weisslukas antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT schlattaualexander antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT hufnaglclemens antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT rickengerda antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT hoftbergerromana antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT greilrichard antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer AT eglealexander antihuantibodyassociatedparaneoplasticcerebellardegenerationinheadandneckcancer |